Publications by authors named "Ruthild Linse"

Claim this Profile
H
Health-related quality of life before and during adjuvant interferon-α treatment for patients with malignant melanoma (DeCOG-trial).
Susanne Ziefle, Friederike Egberts, Sarah Heinze, Matthias Volkenandt, Monika Schmid-Wendtner, Ruthild Linse

J Immunother· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of low-dose interferon {alpha}2a 18 versus 60 months of treatment in patients with primary melanoma of >= 1.5 mm tumor thickness: results of a randomized phase III DeCOG trial.
Axel Hauschild, Michael Weichenthal, Knuth Rass, Ruthild Linse, Carola Berking

J Clin Oncol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trial.
Sarah Heinze, Friederike Egberts, Susanne Rötzer, Matthias Volkenandt, Wolfgang Tilgen, Ruthild Linse

J Immunother· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective randomized multicenter adjuvant dermatologic cooperative oncology group trial of low-dose interferon alfa-2b with or without a modified high-dose interferon alfa-2b induction phase in patients with lymph node-negative melanoma.
Axel Hauschild, Michael Weichenthal, Knuth Rass, Ruthild Linse, Jens Ulrich

J Clin Oncol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant treatment with vindesine in comparison to observation alone in patients with metastasized melanoma after complete metastasectomy: a randomized multicenter trial of the German Dermatologic Cooperative Oncology Group.
Thomas K Eigentler, Peter Radny, Axel Hauschild, Ralf Gutzmer, Ruthild Linse

Melanoma Res· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival benefit after adjuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha: A controlled, randomised multicentre trial.
Rudolf Stadler, Thomas Luger, Thomas Bieber, Ulrike Köhler, Ruthild Linse

Acta Oncol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group.
Roland Kaufmann, Konstanze Spieth, Ulrike Leiter, Cornelia Mauch, Peter von den Driesch, Ruthild Linse

J Clin Oncol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study.
Ellen Rose, Sabine Wever, Detlef Zilliken, Ruthild Linse, Uwe-Frithjof Haustein

J Dtsch Dermatol Ges· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis